Search

Your search keyword '"Anna Licata"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Anna Licata" Remove constraint Author: "Anna Licata"
194 results on '"Anna Licata"'

Search Results

1. Sodium-glucose cotransporter 2 inhibition in patients with liver cirrhosis and diabetes: a possible role in ascites control?

2. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

3. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis

4. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

5. Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)

6. Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome

7. N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review

8. N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review

9. Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease?

10. EVOO’s Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy?

11. SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease

12. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study

13. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

16. Optimizing diagnostic approach to drug-induced liver injury

17. Inflammation and Aortic Stiffness: An Individual Participant Data Meta‐Analysis in Patients With Inflammatory Bowel Disease

19. Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.

20. NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.

21. PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.

22. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis

23. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

24. Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population

25. Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

26. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

27. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

28. COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward

29. Liver injury, SARS‐COV‐2 infection and COVID‐19: What physicians should really know?

30. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

31. Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes

32. The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center

33. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

34. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

35. Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease?

36. Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study

37. Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

39. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort

40. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

41. What changed in the Italian internal medicine and geriatric wards during the lockdown

42. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge

43. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

44. Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort

45. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

46. Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects

47. Drug Induced Liver Injury (Dili) and Non Alcoholic Fatty Liver Disease (Nafld)

48. Pain and Frailty in Hospitalized Older Adults

49. Rivaroxaban-induced hepatotoxicity

50. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?

Catalog

Books, media, physical & digital resources